Author:
Winkelhagen Annemarie J.S.,Mank Theo,de Vries Peter J.,Soetekouw Robin
Publisher
Centers for Disease Control and Prevention (CDC)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference9 articles.
1. Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.;Devine;Vet Parasitol,2012
2. Eberhard M, Engels D. Fascioliasis. In: Heymann DL, editor. Control of communicable diseases manual, 19th ed. Washington (DC): American Public Health Association; 2008. p. 230–1.
3. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control.;Mas-Coma;Adv Parasitol,2009
4. Fasciola hepatica infection; an unusual cause of severe anemia;Wagener;Ned Tijdschr Geneeskd,1972
5. Lack of reversion in triclabendazole-resistant Fasciola hepatica.;Borgsteede;Vet Rec,2005
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献